Budi Starch Sweetener Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Budi Starch Sweetener Tbk trades at Rp206 (market cap 926.79B, 1.1K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 33.1K 24h volume). The key difference: Budi Starch Sweetener Tbk is far larger — about 5.5× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (33.1K versus 1.1K). Which is the better fit depends on your goals.
| BUDI | OBAT | |
|---|---|---|
Market Cap | 926.79B | 167.37B |
Volume | 1.1K | 33.1K |
Lot | 11 | 331 |
Turnover | 226.6K | 8.17M |
Average Price | 206 | 246.91 |
Value | 226.6K | 8.17M |
Indicative Equilibrium Price | — | 246 |
Indicative Equilibrium Volume | — | 2.4K |
Trailing returns across standard periods
Latest headlines on both assets
PT Budi Starch & Sweetener Tbk (the Company) formerly Budi Acid Jaya (BAJ) was established based on Notarial Deed No. 15 dated January 15, 1979 of Henk Limanow, SH., public notary in Jakarta. PT Budi Starch & Sweetener Tbk is the world`s largest tapioca starch producer. BAJ is an integrated cassava based manufacturer : citric acid, modified tapioca starch and monosodium glutamate (MSG). It also produces sulphuric acid and poly propelene woven bag.
Read more on BUDI →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →